Here are relevant reports on : adult-entertainment-market
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Non-Woven Adhesives Market by Technology (Hot-melt), Type (SBC, APAO, EVA), Application (Baby Care, Feminine Hygiene, Adult Incontinence, Medical), and Region - Global Forecast to 2025
The non-woven adhesives market size is projected reach USD 3.5 billion by 2025, at a CAGR of 8.5% during the projected period. Key players profiled in the report include Henkel AG (Germany), H.B. Fuller (US), Arkema (France), Moresco Corporation (Japan), Beardow Adams (Adhesives) Ltd. (UK), Lohmann- Koester GmbH & Co.KG (Germany), ADTEK Malaysia Sdn Bhd (Malaysia), Colquimica Adhesives (Portugal), Savare Specialty Adhesives (Italy), and Palmetto Adhesives Company, Inc. (US).
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Medical Humidifier Market by Product (Heated, Heat & Moisture Exchangers, Humidifier Accessories), Application (ICUs , Neonatal Care),Distribution Channel (Online), Patient Type (Adult), End user (Hospitals) and Region - Global Forecast to 2029
Global medical humidifier market valued at $878.4M in 2023, reached $922.8M in 2024, and is projected to grow at a robust 5.6% CAGR, hitting $1,211.7M by 2029. The high growth rate of the APAC is attributed to the shift toward home healthcare due to cost savings and patient preference, rising birth rates & neonatal respiratory issues, and heavy investments in hospital infrastructure, ICU capacity, and medical device innovation.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Continuous Renal Replacement Therapy Market by Product (Hemofilter, Bloodline, Machines, Dialysates), Modality (SCUF, CVVH, CVVHD, CVVHDF), Age (Adult, Pediatric), Enduser (Hospitals, Ambulatory), and Region - Global Forecast to 2028
The global continuous renal replacement therapy market, valued at US$1.3 billion in 2022, stood at US$1.4 billion in 2023 and is projected to advance at a resilient CAGR of 8.1% from 2023 to 2028, culminating in a forecasted valuation of US$2.1 billion by the end of the period. Various factors such as rise in worldwide prevalence of AKI, Growing number of ICU patients with AKI and rising incidences of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are factors likely to accelerate the growth of the market.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume & Region - Global Forecasts to 2025
The global resuscitation devices market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $8.7 billion by 2025, growing at a CAGR of 4.7% from 2020 to 2025. Prominent players in this market includes Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed Inc. (US), Physio-Control (acquired by Stryker Corporation) (US), Drägerwerk AG & Co. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).
- Published: March 2020
- Price: $ 4950
- TOC Available:
-
CAR T-cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target Antigen (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), End User & Region - Global Forecast to 2029
The global CAR T-cell therapy market, valued at US$3.7 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 39.6% from 2024 to 2029, culminating in a forecasted valuation of US$29.0 billion by the end of the period. The growth of this market due to the rise in investments and funding for CAR T-cell therapy developments and technological advancements in CAR T-cell therapy.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029
The global ventilators market, valued at US$3.86B in 2023, is forecasted to grow at a 4.7% CAGR, reaching US$3.71B by 2024 and US$4.66B by 2029. The demand for invasive and non-invasive ventilator systems has increased due to the rapidly growing geriatric population and the increasing rates of respiratory diseases such as pneumonia, ARDS, and COPD.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029
The global bunion surgery market, valued at US$437.8 million in 2023, stood at US$458.4 million in 2024 and is projected to advance at a resilient CAGR of 5.7% from 2024 to 2029, culminating in a forecasted valuation of US$606.1 million by the end of the period. The main factor driving this market is the rising prevalence of bunions, which has led to an increased demand for surgical treatments.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage Alteration), Therapeutic Application (Pain Management, HRT), Sterility (Sterile), End User (Pediatric, Adult) - Global forecast to 2030
The global Compounding Pharmacy market, valued at US$13.48 billion in 2024, stood at US$14.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$19.41 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Sinus Dilation Devices Market by Product (Balloon Dilation Devices, Endoscope (Rhinoscope, Sinoscope), Handheld), Procedure (Standalone, Hybrid), Patient Type (Adult, Pediatric) & Patient Care Setting (Hospitals & ASC, ENT Office) - Global Forecast to 2027
The global sinus dilation devices market growth is primed to transition from USD 2.8 billion in 2022 to USD 3.8 billion by 2027, showcasing a strong CAGR of 6.6%. The expansion of this market is due in large part to the upsurge in cases of chronic sinusitis as well as growing healthcare spending. However, a lack of skilled ENT professionals is one of the challenges that may inhibit the growth of this market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
